rss
Ann Rheum Dis 1997;56:194-196 doi:10.1136/ard.56.3.194
  • Concise reports

Thrombocytopenia in the antiphospholipid syndrome

  1. Maria José Cuadradoa,
  2. Fedza Mujicb,
  3. Elisa Muñozc,
  4. Munther A Khamashtab,
  5. Graham R V Hughesb
  1. aSección de Reumatologia, Hospital “Reina Sofia”, Cordoba, Spain , bLupus Arthritis Research Unit, The Rayne Institute, St Thomas’s Hospital, London , cDepartamento de Biostadistica, Facultad de Medicina, Universidad de Cordoba, Spain
  1. Dr Munther A Khamashta, Lupus Research Unit, The Rayne Institute, St Thomas’s Hospital, London SE1 7EH.
  • Accepted 26 November 1996

Abstract

OBJECTIVE To determine the prevalence of thrombocytopenia in a group of patients suffering from the antiphospholipid syndrome (APS) and to investigate whether these patients may have any particular clinical or serological features.

METHODS Retrospective analysis. A group of 171 APS patients seen in our department were studied for the presence of thrombocytopenia. Clinical and serological features of these patients were analysed by standard methods and each of them was correlated to the presence of thrombocytopenia and compared with those found in the group without thrombocytopenia.

RESULTS Each of the patients studied had a minimum of three platelet counts during the follow up period. Forty (23.4%) were found to have thrombocytopenia; 13 with persistently low and 27 patients with intermittently low platelet counts. There were no statistically significant differences in sex, age, disease duration or diagnosis when compared with the group of APS patients without thrombocytopenia. Thrombocytopenia was associated with thrombosis in 18, with miscarriages in five, and with both of these features in 13 patients. It was the only manifestation of the APS in four patients. All patients had persistently positive tests for antiphospholipid antibodies concomitantly with the low platelet counts. No significant association was found between the presence of thrombocytopenia and clinical or serological manifestations in APS patients.

CONCLUSION This study showed a prevalence of thrombocytopenia of 23.4% in APS. These patients did not present any significant clinical or serological features that distinguish them from those patients without thrombocytopenia.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content


    Free trial
    Individuals may register for a free 60 day online trial to all content.

    Free archive
    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.